Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Molecular Oncology|December 16, 2024
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibitionElena N C Schmidt, Bernd O Evert, Barbara E F Pregler, et al.
Plos One|September 23, 2025
Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical noteAnna-Laura Potthoff, Meng-Chun Hsieh, Ahmad Melhem, et al.
Scientific Reports|April 5, 2018
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approachMelanie Mettang, Viola Meyer-Pannwitt, Georg Karpel-Massler, et al.
The Journal of Clinical Investigation|April 22, 2020
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma modelsTrang Thi Thu Nguyen, Yiru Zhang, Enyuan Shang, et al.
Neuro-Oncology Advances|August 11, 2021
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3Marc-Eric Halatsch, Richard E Kast, Georg Karpel-Massler, et al.
Theranostics|June 7, 2021
What Animal Cancers teach us about Human BiologyPatricia Kattner, Katharina Zeiler, Verena J Herbener, et al.
Neuro-Oncology|April 17, 2021
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastomaMatthias Schneider, Lea Vollmer, Anna-Laura Potthoff, et al.
Pageof 9